Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.

scientific article published on 28 August 2014

Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/LIV.12655
P698PubMed publication ID25113058

P2093author name stringJing Zeng
Yong Yang
Zhi Wang
Jian Cui
Bing Chen
Bin Yi
Jian T Gu
Jiao L Ning
Kai Z Lu
P2860cites workEffects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways.Q54341750
Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cellsQ28255283
The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndromeQ28571767
Pulmonary angiogenesis in a rat model of hepatopulmonary syndromeQ33682848
Bile acids trigger cholemic nephropathy in common bile-duct-ligated miceQ34037360
Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat ParkinsonismQ34516390
A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletionQ34914604
Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens myocardial injury and dysfunction in vivo after ischemia/reperfusionQ35064243
Molecular mechanism of apoptosis induction in skin cancer cells by the centipedegrass extractQ35064507
Endothelial transcytotic machinery involves supramolecular protein-lipid complexesQ35585545
Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammationQ36236176
p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKBQ36316304
In vivo knockdown of intersectin-1s alters endothelial cell phenotype and causes microvascular remodeling in the mouse lungsQ36527847
Death receptor 5 mediated-apoptosis contributes to cholestatic liver diseaseQ36825315
Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat.Q37354860
Hypoxic hepatitis - epidemiology, pathophysiology and clinical managementQ37723358
Acute respiratory failure complicating advanced liver disease.Q37996906
Hepatopulmonary syndrome: update on pathogenesis and clinical featuresQ38023147
Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt.Q38508300
Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytesQ39904679
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cellsQ40307011
Aggregatibacter actinomycetemcomitans infection enhances apoptosis in vivo through a caspase-3-dependent mechanism in experimental periodontitisQ42189008
Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndromeQ44108455
Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenalQ44483591
Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidneyQ45116769
Desferrioxamine attenuates minor lung injury following surgical acute liver failureQ46220355
The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in ratsQ46649407
Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injuryQ46953194
Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosisQ47111511
Transient hepatopulmonary syndrome in a patient with acute hepatitis A.Q47619663
TNF-α neutralization improves experimental hepatopulmonary syndrome in ratsQ48482110
Role of nitric oxide in hepatopulmonary syndrome in cirrhotic ratsQ48798433
P433issue4
P921main subjecthepatopulmonary syndromeQ1569573
P304page(s)1373-1382
P577publication date2014-08-28
P1433published inLiver InternationalQ15765078
P1476titleCaspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
P478volume35

Reverse relations

cites work (P2860)
Q91173597Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome
Q38334735Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment
Q26739041Hepatopulmonary syndrome: What we know and what we would like to know
Q37144534Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome
Q92689429Krüppel-like factor 6 mediates pulmonary angiogenesis in rat experimental hepatopulmonary syndrome and is aggravated by bone morphogenetic protein 9
Q47746484Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice
Q64066263Postoperative remote lung injury and its impact on surgical outcome
Q57119445Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models
Q47438323The angiogenic related functions of bone marrow mesenchymal stem cells are promoted by CBDL rat serum via the Akt/Nrf2 pathway

Search more.